{"id":741705,"date":"2023-03-21T16:09:55","date_gmt":"2023-03-21T20:09:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/"},"modified":"2023-03-21T16:09:55","modified_gmt":"2023-03-21T20:09:55","slug":"pepgen-to-participate-in-the-stifel-2023-cns-days-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/","title":{"rendered":"PepGen to Participate in the Stifel 2023 CNS Days Conference"},"content":{"rendered":"
\n

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,\u00a0today announced that James McArthur, Ph.D., President and CEO of PepGen will present at Stifel\u2019s CNS Days Conference on Tuesday, March 28th<\/sup> at 1:30pm EST.<\/p>\n

The event will be webcast live under the Events & Presentations<\/a> section of the Investor Relations<\/a> section of PepGen\u2019s website. A replay of the event will be archived for one year.<\/p>\n

\n About PepGen<\/strong>\n <\/p>\n

PepGen Inc. is a clinical-stage biotechnology company\u202fadvancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen\u2019s Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the root cause of serious diseases.<\/strong><\/p>\n

\n Investor Contact<\/strong>
\n
Laurence Watts
Gilmartin Group
Laurence@gilmartinir.com<\/u><\/a>\u00a0\u00a0<\/p>\n

\n Media Contact<\/strong>
\n
Gwendolyn Schanker
LifeSci Communications
gschanker@lifescicomms.com<\/u><\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,\u00a0today announced that James McArthur, Ph.D., President and CEO of PepGen will present at Stifel\u2019s CNS Days Conference on Tuesday, March 28th at 1:30pm EST. The event will be webcast live under the Events & Presentations section of the Investor Relations section of PepGen\u2019s website. A replay of the event will be archived for one year. About PepGen PepGen Inc. is a clinical-stage biotechnology company\u202fadvancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen\u2019s Enhanced Delivery … <\/p>\n

Continue reading “PepGen to Participate in the Stifel 2023 CNS Days Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-741705","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPepGen to Participate in the Stifel 2023 CNS Days Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PepGen to Participate in the Stifel 2023 CNS Days Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, March 21, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,\u00a0today announced that James McArthur, Ph.D., President and CEO of PepGen will present at Stifel\u2019s CNS Days Conference on Tuesday, March 28th at 1:30pm EST. The event will be webcast live under the Events & Presentations section of the Investor Relations section of PepGen\u2019s website. A replay of the event will be archived for one year. About PepGen PepGen Inc. is a clinical-stage biotechnology company\u202fadvancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen\u2019s Enhanced Delivery … Continue reading "PepGen to Participate in the Stifel 2023 CNS Days Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T20:09:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PepGen to Participate in the Stifel 2023 CNS Days Conference\",\"datePublished\":\"2023-03-21T20:09:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/\"},\"wordCount\":198,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/\",\"name\":\"PepGen to Participate in the Stifel 2023 CNS Days Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=\",\"datePublished\":\"2023-03-21T20:09:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PepGen to Participate in the Stifel 2023 CNS Days Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PepGen to Participate in the Stifel 2023 CNS Days Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/","og_locale":"en_US","og_type":"article","og_title":"PepGen to Participate in the Stifel 2023 CNS Days Conference - Market Newsdesk","og_description":"BOSTON, March 21, 2023 (GLOBE NEWSWIRE) — PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,\u00a0today announced that James McArthur, Ph.D., President and CEO of PepGen will present at Stifel\u2019s CNS Days Conference on Tuesday, March 28th at 1:30pm EST. The event will be webcast live under the Events & Presentations section of the Investor Relations section of PepGen\u2019s website. A replay of the event will be archived for one year. About PepGen PepGen Inc. is a clinical-stage biotechnology company\u202fadvancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen\u2019s Enhanced Delivery … Continue reading \"PepGen to Participate in the Stifel 2023 CNS Days Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-21T20:09:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PepGen to Participate in the Stifel 2023 CNS Days Conference","datePublished":"2023-03-21T20:09:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/"},"wordCount":198,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/","name":"PepGen to Participate in the Stifel 2023 CNS Days Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=","datePublished":"2023-03-21T20:09:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjgyOSM1NDc0NDY3IzIyMTEyNDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pepgen-to-participate-in-the-stifel-2023-cns-days-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PepGen to Participate in the Stifel 2023 CNS Days Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=741705"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741705\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=741705"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=741705"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=741705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}